November 19, 2025 Announcement no. 26 BioPorto Interim Result for the Third Quarter of 2025 – Continued progress and continued…
Lunsumio provides high rates of deep and long-lasting responses in third-line and later follicular lymphoma, a disease that typically becomes…
SANTA CLARA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving…
SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical…
BEIJING, Nov. 19, 2025 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance…
New integrated workspace will combine the broadest collection of trusted scientific content with responsible AI to help researchers move from…
DUBAI, UAE, Nov. 19, 2025 /PRNewswire/ -- TruDoc Healthcare, the largest telehealth provider in the Middle East, has launched its…
BEIRUT, Nov. 19, 2025 /PRNewswire/ -- Nextcare Lebanon and MEDGULF Insurance and Reinsurance have formed a strategic partnership to improve…
Modern SaaS-native platform to streamline operations, unify data and support institutional excellence at the United Arab Emirates' first specialized medical…
Calgary, Alberta--(Newsfile Corp. - November 18, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"),…